Role of CITED2 in stem cells and cancer (Review)
- Authors:
- Beiying An
- Xufeng Ji
- Yubao Gong
-
Affiliations: Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China, Department of Orthopaedics, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China - Published online on: August 10, 2020 https://doi.org/10.3892/ol.2020.11968
- Article Number: 107
-
Copyright: © An et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI | |
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI | |
Lampe JW: Dairy products and cancer. J Am Coll Nutr. 30 (5 Suppl 1):464S–470S. 2011. View Article : Google Scholar : PubMed/NCBI | |
Lambert M, Jambon S, Depauw S and David-Cordonnier MH: Targeting transcription factors for cancer treatment. Molecules. 23:14792018. View Article : Google Scholar | |
Bushweller JH: Targeting transcription factors in cancer-from undruggable to reality. Nat Rev Cancer. 19:611–624. 2019. View Article : Google Scholar : PubMed/NCBI | |
Shioda T, Fenner MH and Isselbacher KJ: MSG1 and its related protein MRG1 share a transcription activating domain. Gene. 204:235–241. 1997. View Article : Google Scholar : PubMed/NCBI | |
Sun HB, Zhu YX, Yin T, Sledge G and Yang YC: MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity. Proc Natl Acad Sci USA. 95:13555–13560. 1998. View Article : Google Scholar : PubMed/NCBI | |
Bamforth SD, Braganca J, Eloranta JJ, Murdoch JN, Marques FI, Kranc KR, Farza H, Henderson DJ, Hurst HC and Bhattacharya S: Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat Genet. 29:469–474. 2001. View Article : Google Scholar : PubMed/NCBI | |
Yin Z, Haynie J, Yang X, Han B, Kiatchoosakun S, Restivo J, Yuan S, Prabhakar NR, Herrup K, Conlon RA, et al: The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Proc Natl Acad Sci USA. 99:10488–10493. 2002. View Article : Google Scholar : PubMed/NCBI | |
Qu X, Lam E, Doughman YQ, Chen Y, Chou YT, Lam M, Turakhia M, Dunwoodie SL, Watanabe M, Xu B, et al: Cited2, a coactivator of HNF4alpha, is essential for liver development. EMBO J. 26:4445–4456. 2007. View Article : Google Scholar : PubMed/NCBI | |
Xu B, Qu X, Gu S, Doughman YQ, Watanabe M, Dunwoodie SL and Yang YC: Cited2 is required for fetal lung maturation. Dev Biol. 317:95–105. 2008. View Article : Google Scholar : PubMed/NCBI | |
Bamforth SD, Braganca J, Farthing CR, Schneider JE, Broadbent C, Michell AC, Clarke K, Neubauer S, Norris D, Brown NA, et al: Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat Genet. 36:1189–1196. 2004. View Article : Google Scholar : PubMed/NCBI | |
Huang TQ, Wang Y, Ebrahem Q, Chen Y, Cheng C, Doughman YQ, Watanabe M, Dunwoodie SL and Yang YC: Deletion of HIF-1α partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes. Mol Vis. 18:1260–1270. 2012.PubMed/NCBI | |
Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL and Livingston DM: Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13:64–75. 1999. View Article : Google Scholar : PubMed/NCBI | |
Glenn DJ and Maurer RA: MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein hormone alpha-subunit gene expression. J Biol Chem. 274:36159–36167. 1999. View Article : Google Scholar : PubMed/NCBI | |
Bragança J, Eloranta JJ, Bamforth SD, Ibbitt JC, Hurst HC and Bhattacharya S: Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J Biol Chem. 278:16021–16029. 2003. View Article : Google Scholar : PubMed/NCBI | |
Tien ES, Davis JW and Vanden Heuvel JP: Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator. J Biol Chem. 279:24053–24063. 2004. View Article : Google Scholar : PubMed/NCBI | |
Chou YT, Wang H, Chen Y, Danielpour D and Yang YC: Cited2 modulates TGF-beta-mediated upregulation of MMP9. Oncogene. 25:5547–5560. 2006. View Article : Google Scholar : PubMed/NCBI | |
Lau WM, Doucet M, Huang D, Weber KL and Kominsky SL: CITED2 modulates estrogen receptor transcriptional activity in breast cancer cells. Biochem Biophys Res Commun. 437:261–266. 2013. View Article : Google Scholar : PubMed/NCBI | |
Fujita M, Takasaki T, Nakajima N, Kawano T, Shimura Y and Sakamoto H: MRG-1, a mortality factor-related chromodomain protein, is required maternally for primordial germ cells to initiate mitotic proliferation in C. Elegans. Mech Dev. 114:61–69. 2002. View Article : Google Scholar : PubMed/NCBI | |
Chou YT, Hsieh CH, Chiou SH, Hsu CF, Kao YR, Lee CC, Chung CH, Wang YH, Hsu HS, Pang ST, et al: CITED2 functions as a molecular switch of cytokine-induced proliferation and quiescence. Cell Death Differ. 19:2015–2028. 2012. View Article : Google Scholar : PubMed/NCBI | |
Shin SH, Lee GY, Lee M, Kang J, Shin HW, Chun YS and Park JW: Aberrant expression of CITED2 promotes prostate cancer metastasis by activating the nucleolin-AKT pathway. Nat Commun. 9:41132018. View Article : Google Scholar : PubMed/NCBI | |
Kranc KR, Bamforth SD, Braganca J, Norbury C, van Lohuizen M and Bhattacharya S: Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF. Mol Cell Biol. 23:7658–7666. 2003. View Article : Google Scholar : PubMed/NCBI | |
Regel I, Merkl L, Friedrich T, Burgermeister E, Zimmermann W, Einwächter H, Herrmann K, Langer R, Röcken C, Hofheinz R, et al: Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2. Gastroenterology. 143:99–109.e10. 2012. View Article : Google Scholar : PubMed/NCBI | |
Lau WM, Weber KL, Doucet M, Chou YT, Brady K, Kowalski J, Tsai HL, Yang J and Kominsky SL: Identification of prospective factors promoting osteotropism in breast cancer: A potential role for CITED2. Int J Cancer. 126:876–884. 2010.PubMed/NCBI | |
Jayaraman S, Doucet M, Lau WM and Kominsky SL: CITED2 modulates breast cancer metastatic ability through effects on IKKα. Mol Cancer Res. 14:730–739. 2016. View Article : Google Scholar : PubMed/NCBI | |
Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature. 414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI | |
Chen W, Dong J, Haiech J, Kilhoffer MC and Zeniou M: Cancer stem cell quiescence and plasticity as major challenges in cancer therapy. Stem Cells Int. 2016:17409362016. View Article : Google Scholar : PubMed/NCBI | |
Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F and Cui H: Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 5:82020. View Article : Google Scholar : PubMed/NCBI | |
Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J and Terzis AJ: Opinion: The origin of the cancer stem cell: Current controversies and new insights. Nat Rev Cancer. 5:899–904. 2005. View Article : Google Scholar : PubMed/NCBI | |
Pugh CW: Modulation of the hypoxic response. Adv Exp Med Biol. 903:259–271. 2016. View Article : Google Scholar : PubMed/NCBI | |
Gezer D, Vukovic M, Soga T, Pollard PJ and Kranc KR: Concise review: genetic dissection of hypoxia signaling pathways in normal and leukemic stem cells. Stem Cells. 32:1390–1397. 2014. View Article : Google Scholar : PubMed/NCBI | |
Du J and Yang YC: HIF-1 and its antagonist Cited2: Regulators of HSC quiescence. Cell Cycle. 11:2413–2414. 2012. View Article : Google Scholar : PubMed/NCBI | |
Henze AT and Acker T: Feedback regulators of hypoxia-inducible factors and their role in cancer biology. Cell Cycle. 9:2749–2763. 2010. View Article : Google Scholar : PubMed/NCBI | |
De Guzman RN, Martinez-Yamout MA, Dyson HJ and Wright PE: Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: Regulation by competition between intrinsically unstructured ligands for non-identical binding sites. J Biol Chem. 279:3042–3049. 2004. View Article : Google Scholar : PubMed/NCBI | |
Matt T, Martinez-Yamout MA, Dyson HJ and Wright PE: The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2. Biochem J. 381:685–691. 2004. View Article : Google Scholar : PubMed/NCBI | |
Yoon H, Lim JH, Cho CH, Huang LE and Park JW: CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α. Biochim Biophys Acta. 1813:2008–2016. 2011. View Article : Google Scholar : PubMed/NCBI | |
Berlow RB, Martinez-Yamout MA, Dyson HJ and Wright PE: Role of backbone dynamics in modulating the interactions of disordered ligands with the TAZ1 domain of the CREB-binding protein. Biochemistry. 58:1354–1362. 2019. View Article : Google Scholar : PubMed/NCBI | |
Ruiz-Ortiz I and De Sancho D: Competitive binding of HIF-1α and CITED2 to the TAZ1 domain of CBP from molecular simulations. Phys Chem Chem Phys. 22:8118–8127. 2020. View Article : Google Scholar : PubMed/NCBI | |
Chen CM, Bentham J, Cosgrove C, Braganca J, Cuenda A, Bamforth SD, Schneider JE, Watkins H, Keavney B, Davies B and Bhattacharya S: Functional significance of SRJ domain mutations in CITED2. PLoS One. 7:e462562012. View Article : Google Scholar : PubMed/NCBI | |
MacDonald ST, Bamforth SD, Braganca J, Chen CM, Broadbent C, Schneider JE, Schwartz RJ and Bhattacharya S: A cell-autonomous role of Cited2 in controlling myocardial and coronary vascular development. Eur Heart J. 34:2557–2565. 2013. View Article : Google Scholar : PubMed/NCBI | |
Jayaraman S, Doucet M and Kominsky SL: Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA. Oncotarget. 8:6169–6178. 2017. View Article : Google Scholar : PubMed/NCBI | |
Gonzalez YR, Zhang Y, Behzadpoor D, Cregan S, Bamforth S, Slack RS and Park DS: CITED2 signals through peroxisome proliferator-activated receptor-gamma to regulate death of cortical neurons after DNA damage. J Neurosci. 28:5559–5569. 2008. View Article : Google Scholar : PubMed/NCBI | |
Kim GD, Das R, Rao X, Zhong J, Deiuliis JA, Ramirez-Bergeron DL, Rajagopalan S and Mahabeleshwar GH: CITED2 restrains proinflammatory macrophage activation and response. Mol Cell Biol. 38:e00452–17. 2018.PubMed/NCBI | |
Liu Z, Wang Y, Dou C, Sun L, Li Q, Wang L, Xu Q, Yang W, Liu Q and Tu K: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma. J Exp Clin Cancer Res. 37:492018. View Article : Google Scholar : PubMed/NCBI | |
Buaas FW, Val P and Swain A: The transcription co-factor CITED2 functions during sex determination and early gonad development. Hum Mol Genet. 18:2989–3001. 2009. View Article : Google Scholar : PubMed/NCBI | |
Val P, Martinez-Barbera JP and Swain A: Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage. Development. 134:2349–2358. 2007. View Article : Google Scholar : PubMed/NCBI | |
Weninger WJ, Lopes Floro K, Bennett MB, Withington SL, Preis JI, Barbera JP, Mohun TJ and Dunwoodie SL: Cited2 is required both for heart morphogenesis and establishment of the left-right axis in mouse development. Development. 132:1337–1348. 2005. View Article : Google Scholar : PubMed/NCBI | |
Bentham J, Michell AC, Lockstone H, Andrew D, Schneider JE, Brown NA and Bhattacharya S: Maternal high-fat diet interacts with embryonic Cited2 genotype to reduce Pitx2c expression and enhance penetrance of left-right patterning defects. Hum Mol Genet. 19:3394–3401. 2010. View Article : Google Scholar : PubMed/NCBI | |
Lopes Floro K, Artap ST, Preis JI, Fatkin D, Chapman G, Furtado MB, Harvey RP, Hamada H, Sparrow DB and Dunwoodie SL: Loss of Cited2 causes congenital heart disease by perturbing left-right patterning of the body axis. Hum Mol Genet. 20:1097–1110. 2011. View Article : Google Scholar : PubMed/NCBI | |
Combes AN, Spiller CM, Harley VR, Sinclair AH, Dunwoodie SL, Wilhelm D and Koopman P: Gonadal defects in Cited2-mutant mice indicate a role for SF1 in both testis and ovary differentiation. Int J Dev Biol. 54:683–689. 2010. View Article : Google Scholar : PubMed/NCBI | |
Berlow RB, Dyson HJ and Wright PE: Hypersensitive termination of the hypoxic response by a disordered protein switch. Nature. 543:447–451. 2017. View Article : Google Scholar : PubMed/NCBI | |
Shin DH, Li SH, Chun YS, Huang LE, Kim MS and Park JW: CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition. Oncogene. 27:1939–1944. 2008. View Article : Google Scholar : PubMed/NCBI | |
Freedman SJ, Sun ZY, Kung AL, France DS, Wagner G and Eck MJ: Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat Struct Biol. 10:504–512. 2003. View Article : Google Scholar : PubMed/NCBI | |
Yokota H, Goldring MB and Sun HB: CITED2-mediated regulation of MMP-1 and MMP-13 in human chondrocytes under flow shear. J Biol Chem. 278:47275–47280. 2003. View Article : Google Scholar : PubMed/NCBI | |
He Z, Leong DJ, Zhuo Z, Majeska RJ, Cardoso L, Spray DC, Goldring MB, Cobelli NJ and Sun HB: Strain-induced mechanotransduction through primary cilia, extracellular ATP, purinergic calcium signaling, and ERK1/2 transactivates CITED2 and downregulates MMP-1 and MMP-13 gene expression in chondrocytes. Osteoarthritis Cartilage. 24:892–901. 2016. View Article : Google Scholar : PubMed/NCBI | |
He Z, Leong DJ, Xu L, Hardin JA, Majeska RJ, Schaffler MB, Thi MM, Yang L, Goldring MB, Cobelli NJ and Sun HB: CITED2 mediates the cross-talk between mechanical loading and IL-4 to promote chondroprotection. Ann N Y Acad Sci. 1442:128–137. 2019. View Article : Google Scholar : PubMed/NCBI | |
Pacheco-Leyva I, Matias AC, Oliveira DV, Santos JM, Nascimento R, Guerreiro E, Michell AC, van De Vrugt AM, Machado-Oliveira G, Ferreira G, et al: CITED2 cooperates with ISL1 and promotes cardiac differentiation of mouse embryonic stem cells. Stem Cell Reports. 7:1037–1049. 2016. View Article : Google Scholar : PubMed/NCBI | |
Guo T, Wen XZ, Li ZY, Han HB, Zhang CG, Bai YH, Xing XF, Cheng XJ, Du H, Hu Y, et al: ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7. Cell Death Dis. 10:332019. View Article : Google Scholar : PubMed/NCBI | |
Zhang Y, Wang L, Gao P, Sun Z, Li N, Lu Y, Shen J, Sun J, Yang Y, Dai H and Cai H: ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple-negative breast cancer cells. Int J Mol Med. 42:2343–2352. 2018.PubMed/NCBI | |
Li L, Sun F, Chen X and Zhang M: ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis. Onco Targets Ther. 11:781–789. 2018. View Article : Google Scholar : PubMed/NCBI | |
Chen Y, Haviernik P, Bunting KD and Yang YC: Cited2 is required for normal hematopoiesis in the murine fetal liver. Blood. 110:2889–2898. 2007. View Article : Google Scholar : PubMed/NCBI | |
Kranc KR, Schepers H, Rodrigues NP, Bamforth S, Villadsen E, Ferry H, Bouriez-Jones T, Sigvardsson M, Bhattacharya S, Jacobsen SE and Enver T: Cited2 is an essential regulator of adult hematopoietic stem cells. Cell Stem Cell. 5:659–665. 2009. View Article : Google Scholar : PubMed/NCBI | |
Du J and Yang YC: Cited2 in hematopoietic stem cell function. Curr Opin Hematol. 20:301–307. 2013. View Article : Google Scholar : PubMed/NCBI | |
Korthuis PM, Berger G, Bakker B, Rozenveld-Geugien M, Jaques J, de Haan G, Schuringa JJ, Vellenga E and Schepers H: CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia. Leukemia. 29:625–635. 2015. View Article : Google Scholar : PubMed/NCBI | |
Mattes K, Geugien M, Korthuis PM, Brouwers-Vos AZ, Fehrmann RSN, Todorova TI, Steidl U, Vellenga E and Schepers H: Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells. Exp Hematol. 73:38–49.e7. 2019. View Article : Google Scholar : PubMed/NCBI | |
Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, et al: Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med. 13:1219–1227. 2007. View Article : Google Scholar : PubMed/NCBI | |
Zhou Z, Akinbiyi T, Xu L, Ramcharan M, Leong DJ, Ros SJ, Colvin AC, Schaffler MB, Majeska RJ, Flatow EL and Sun HB: Tendon-derived stem/progenitor cell aging: Defective self-renewal and altered fate. Aging Cell. 9:911–915. 2010. View Article : Google Scholar : PubMed/NCBI | |
Hu C, Zhang Y, Tang K, Luo Y, Liu Y and Chen W: Downregulation of CITED2 contributes to TGFβ-mediated senescence of tendon-derived stem cells. Cell Tissue Res. 368:93–104. 2017. View Article : Google Scholar : PubMed/NCBI | |
AlAbdi L, He M, Yang Q, Norvil AB and Gowher H: The transcription factor Vezf1 represses the expression of the antiangiogenic factor Cited2 in endothelial cells. J Biol Chem. 293:11109–11118. 2018. View Article : Google Scholar : PubMed/NCBI | |
Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, et al: Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell. 133:1106–1117. 2008. View Article : Google Scholar : PubMed/NCBI | |
Zhong X and Jin Y: Critical roles of coactivator p300 in mouse embryonic stem cell differentiation and Nanog expression. J Biol Chem. 284:9168–9175. 2009. View Article : Google Scholar : PubMed/NCBI | |
Pritsker M, Ford NR, Jenq HT and Lemischka IR: Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells. Proc Natl Acad Sci USA. 103:6946–6951. 2006. View Article : Google Scholar : PubMed/NCBI | |
Li Q, Ramirez-Bergeron DL, Dunwoodie SL and Yang YC: Cited2 gene controls pluripotency and cardiomyocyte differentiation of murine embryonic stem cells through Oct4 gene. J Biol Chem. 287:29088–29100. 2012. View Article : Google Scholar : PubMed/NCBI | |
Santos JMA, Mendes-Silva L, Afonso V, Martins G, Machado RSR, Lopes JA, Cancela L, Futschik ME, Sachinidis A, Gavaia P and Bragança J: Exogenous WNT5A and WNT11 proteins rescue CITED2 dysfunction in mouse embryonic stem cells and zebrafish morphants. Cell Death Dis. 10:5822019. View Article : Google Scholar : PubMed/NCBI | |
Kranc KR, Oliveira DV, Armesilla-Diaz A, Pacheco-Leyva I, Catarina Matias A, Luisa Escapa A, Subramani C, Wheadon H, Trindade M, Nichols J, et al: Acute loss of Cited2 impairs Nanog expression and decreases self-renewal of mouse embryonic stem cells. Stem Cells. 33:699–712. 2015. View Article : Google Scholar : PubMed/NCBI | |
Fakunle ES: iPSCs for personalized medicine: What will it take for Africa? Trends Mol Med. 18:695–699. 2012. View Article : Google Scholar : PubMed/NCBI | |
Gurwitz D: Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders. Dialogues Clin Neurosci. 18:267–276. 2016.PubMed/NCBI | |
Takahashi K and Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI | |
Takahashi K, Okita K, Nakagawa M and Yamanaka S: Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc. 2:3081–3089. 2007. View Article : Google Scholar : PubMed/NCBI | |
Charneca J, Matias AC, Escapa AL, Fernandes C, Alves A, Santos JMA, Nascimento R and Bragança J: Ectopic expression of CITED2 prior to reprogramming, promotes and homogenises the conversion of somatic cells into induced pluripotent stem cells. Exp Cell Res. 358:290–300. 2017. View Article : Google Scholar : PubMed/NCBI | |
Li H, Collado M, Villasante A, Strati K, Ortega S, Cañamero M, Blasco MA and Serrano M: The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature. 460:1136–1139. 2009. View Article : Google Scholar : PubMed/NCBI | |
Mahmoudi S and Brunet A: Aging and reprogramming: A two-way street. Curr Opin Cell Biol. 24:744–756. 2012. View Article : Google Scholar : PubMed/NCBI | |
Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et al: A pathology atlas of the human cancer transcriptome. Science. 357:eaan25072017. View Article : Google Scholar : PubMed/NCBI | |
Minemura H, Takagi K, Sato A, Takahashi H, Miki Y, Shibahara Y, Watanabe M, Ishida T, Sasano H and Suzuki T: CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance. Cancer Sci. 107:1898–1908. 2016. View Article : Google Scholar : PubMed/NCBI | |
Yang X, Vasudevan P, Parekh V, Penev A and Cunningham JM: Bridging cancer biology with the clinic: Relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis. PLoS One. 8:e561952013. View Article : Google Scholar : PubMed/NCBI | |
van Agthoven T, Sieuwerts AM, Veldscholte J, Meijer-van Gelder ME, Smid M, Brinkman A, den Dekker AT, Leroy IM, van Ijcken WF, Sleijfer S, et al: CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer. Br J Cancer. 101:1824–1832. 2009. View Article : Google Scholar : PubMed/NCBI | |
De Palma M and Lewis CE: Cancer: Macrophages limit chemotherapy. Nature. 472:303–304. 2011. View Article : Google Scholar : PubMed/NCBI | |
Nielsen SR and Schmid MC: Macrophages as key drivers of cancer progression and metastasis. Mediators Inflamm. 2017:96247602017. View Article : Google Scholar : PubMed/NCBI | |
Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78. 2004. View Article : Google Scholar : PubMed/NCBI | |
Ruffell B and Coussens LM: Macrophages and therapeutic resistance in cancer. Cancer Cell. 27:462–472. 2015. View Article : Google Scholar : PubMed/NCBI | |
Jayaraman S, Doucet M and Kominsky SL: CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells. Oncol Lett. 15:871–878. 2018.PubMed/NCBI | |
Greijer AE and van der Wall E: The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol. 57:1009–1014. 2004. View Article : Google Scholar : PubMed/NCBI | |
Bakker WJ, Harris IS and Mak TW: FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2. Mol Cell. 28:941–953. 2007. View Article : Google Scholar : PubMed/NCBI | |
Du J, Li Q, Tang F, Puchowitz MA, Fujioka H, Dunwoodie SL, Danielpour D and Yang YC: Cited2 is required for the maintenance of glycolytic metabolism in adult hematopoietic stem cells. Stem Cells Dev. 23:83–94. 2014. View Article : Google Scholar : PubMed/NCBI | |
Deschler B and Lübbert M: Acute myeloid leukemia: Epidemiology and etiology. Cancer. 107:2099–2107. 2006. View Article : Google Scholar : PubMed/NCBI | |
Mattes K, Berger G, Geugien M, Vellenga E and Schepers H: CITED2 affects leukemic cell survival by interfering with p53 activation. Cell Death Dis. 8:e31322017. View Article : Google Scholar : PubMed/NCBI | |
Jang SM, An JH, Kim CH, Kim JW and Choi KH: Transcription factor FOXA2-centered transcriptional regulation network in non-small cell lung cancer. Biochem Biophys Res Commun. 463:961–967. 2015. View Article : Google Scholar : PubMed/NCBI | |
Wu ZZ, Sun NK and Chao CC: Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis. J Cell Physiol. 226:2415–2428. 2011. View Article : Google Scholar : PubMed/NCBI | |
Yao Y, Zhang T, Qi L, Liu R, Liu G, Wang X, Li J, Li J and Sun C: Competitive endogenous RNA network construction and comparison of lung squamous cell carcinoma in smokers and nonsmokers. Dis Markers. 2019:52927872019. View Article : Google Scholar : PubMed/NCBI | |
Attard G and Antonarakis ES: Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide. Nat Rev Urol. 13:697–698. 2016. View Article : Google Scholar : PubMed/NCBI | |
Bai L and Merchant JL: A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion. FEBS Lett. 581:5904–5910. 2007. View Article : Google Scholar : PubMed/NCBI | |
Li XX, Zheng HT, Peng JJ, Huang LY, Shi DB, Liang L and Cai SJ: RNA-seq reveals determinants for irinotecan sensitivity/resistance in colorectal cancer cell lines. Int J Clin Exp Pathol. 7:2729–2736. 2014.PubMed/NCBI | |
Zhao X, Cai H, Wang X and Ma L: Discovery of signature genes in gastric cancer associated with prognosis. Neoplasma. 63:239–245. 2016.PubMed/NCBI | |
Dun B, Sharma A, Teng Y, Liu H, Purohit S, Xu H, Zeng L and She JX: Mycophenolic acid inhibits migration and invasion of gastric cancer cells via multiple molecular pathways. PLoS One. 8:e817022013. View Article : Google Scholar : PubMed/NCBI | |
Tang Z, He G, Xu J and Zhongfu L: Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer. J Surg Res. 211:1–7. 2017. View Article : Google Scholar : PubMed/NCBI | |
Barbera JP, Rodriguez TA, Greene ND, Weninger WJ, Simeone A, Copp AJ, Beddington RS and Dunwoodie S: Folic acid prevents exencephaly in Cited2 deficient mice. Hum Mol Genet. 11:283–293. 2002. View Article : Google Scholar : PubMed/NCBI | |
Du J, Chen Y, Li Q, Han X, Cheng C, Wang Z, Danielpour D, Dunwoodie SL, Bunting KD and Yang YC: HIF-1α deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency. Blood. 119:2789–2798. 2012. View Article : Google Scholar : PubMed/NCBI | |
Liu YC, Chang PY and Chao CC: CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene. Nucleic Acids Res. 43:10760–10781. 2015. View Article : Google Scholar : PubMed/NCBI | |
Yoshida T, Sekine T, Aisaki K, Mikami T, Kanno J and Okayasu I: CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid. J Gastroenterol. 46:339–349. 2011. View Article : Google Scholar : PubMed/NCBI | |
Jiang Y, Zhou Z, Fei R, Zhou X, Wang J, Tao Y, Li J and Chen T: Role of miR-182-5p overexpression in trichloroethylene-induced abnormal cell cycle functions in human HepG2 cells. J Toxicol Environ Health A. 82:920–927. 2019. View Article : Google Scholar : PubMed/NCBI | |
Rasti A, Mehrazma M, Madjd Z, Abolhasani M, Saeednejad Zanjani L and Asgari M: Co-expression of cancer stem cell markers OCT4 and NANOG predicts poor prognosis in renal cell carcinomas. Sci Rep. 8:117392018. View Article : Google Scholar : PubMed/NCBI | |
Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI | |
Jeter CR, Yang T, Wang J, Chao HP and Tang DG: Concise review: NANOG in cancer stem cells and tumor development: An update and outstanding questions. Stem Cells. 33:2381–2390. 2015. View Article : Google Scholar : PubMed/NCBI | |
Yu F, Li J, Chen H, Fu J, Ray S, Huang S, Zheng H and Ai W: Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene. 30:2161–2172. 2011. View Article : Google Scholar : PubMed/NCBI | |
Prost S, Relouzat F, Spentchian M, Ouzegdouh Y, Saliba J, Massonnet G, Beressi JP, Verhoeyen E, Raggueneau V, Maneglier B, et al: Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists. Nature. 525:380–383. 2015. View Article : Google Scholar : PubMed/NCBI |